This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
he utility of left atrial appendage occlusion (LAAO) as a therapy for stroke prevention in patients with nonvalvular atrialfibrillation (AFib) is the focus of a State-of-the-Art Review published Jan. 8 in JACC: Clinical Electrophysiology.
Patients who present with persistent atrialfibrillation at diagnosis are more likely to have certain risk factors as compared with patients with occasional atrialfibrillation (AFib).
This trial aims to demonstrate that EGF mapping can be used to identify EGF sources outside the pulmonary veins in all types of patients, including those with paroxysmal, persistent, and long-standing persistent AFib and undergoing de novo or redo procedures. and may enroll up to 400 subjects across 20+ centers in the US and Europe.
It is with great pride that we announce the resounding success of ADN CoE' s AFib Ablation Training program, the second installment in our esteemed Ablation Series, held at the prestigious 9 Eylül University Heart Rhythm Management Centre. Dr. Emin Evren Özcan and Assoc. Oguzhan Ekrem Turan.
Not only do former smokers have lower risk of atrialfibrillation (AFib) than current smokers, but patients who quit smoking may reduce their AFib risk while doing so, according to a longitudinal cohort study utilizing UK Biobank data, published Sept. 11 in JACC: Clinical Electrophysiology.
Definitely atrialfibrillation. Probably WPW but is very slow for atrial fib withWPW. So this looks like WPW with Atrialfibrillation. What is unusual is that the rate is not REALLY fast, as you expect when there is atrial fib with an accessory pathway. My response: "Definitely not polymorphic VT.
Additional rhythm-control strategies are frequently continued after index ablation for atrialfibrillation (AFib), according to a study published Feb. 12 in JACC: Clinical Electrophysiology.
It is with great pride that we announce the resounding success of ADN CoE' s AFib Ablation Training program, the second installment in our esteemed Ablation Series, held at the prestigious 9 Eylül University Heart Rhythm Management Centre. Dr. Emin Evren Özcan and Assoc. Oguzhan Ekrem Turan.
Whenever it is this fast, you need to be very careful to ascertain whether it is irregular ( as in atrialfibrillation with rapid ventricular respsonse ) or regular ( as in VT ). This is not because it is polymorphic VT; it is because it is WPW with atrialfibrillation. Smith : What do you think? It is not VT; it is AF.
In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace.
The first procedures, performed by leading physicians Saibal Kar , MD, FACC, FSCAI, (Program Director, Cardiovascular Disease Fellowship, Los Robles Health System , California, HCA Healthcare National Physician Director, Interventional Cardiology) and Devi Nair , MD, FACC, FHRS, (Director, Cardiac Electrophysiology Division, St.
The AFib pulsed field ablation treatment era officially began in the US last week, following the FDA approval of Medtronic’s PulseSelect Pulsed Field Ablation System for the treatment of both paroxysmal and persistent atrialfibrillation. At 1 year, the PulseSelect PFA was also clinically effective among 66.2%
milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heart rhythms such as atrialfibrillation (AFib).
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrialfibrillation (AFib).
She also has a hx of paroxysmal atrialfibrillation and is on oral anticoagulant treatment. The patient also has a history of AFib and HFmrEF ( = H eart F ailure with M inimally- R educed E jection F raction ). The patient is female in her 80s with a medical hx of previous MI with PCI and stent placement.
Abstract Introduction Atrialfibrillation (Afib) is a prevalent chronic arrhythmia associated with severe complications, including stroke, heart failure, and increased mortality. Results/Observation Current Afib detection methods, such as electrocardiography, have limitations in sensitivity and specificity.
ABSTRACT Background Atrialfibrillation and atrial flutter are relatively rare in young people and the incidence of thromboembolic complications is unknown. Results There were 311 episodes of AFib/AFl among 210 patients with a median age of 17 (IQR 14, 20) years.
Many ECG readers will not comment any further on rhythm once ventricular pacing has been identified, but it is still critical to determine the atrial rhythm. In this case, it is atrialfibrillation. The September 15, 2023 post — for PTA ( Pulse-Tap Artifact ). The March 17, 2023 post — for PTA.
Electrophysiology: This specialized area focuses on heart rhythm problems, like atrialfibrillation (AFib). We offer various diagnostic and treatment options for aFib including pacemaker implantation if needed.
Electrophysiology: This specialized area focuses on heart rhythm problems, like atrialfibrillation (AFib). We offer various diagnostic and treatment options for aFib including pacemaker implantation if needed.
Patient was referred to electrophysiologic testing due to suspicion of afib and WPW. During electrophysiologic testing AVRT was induced, which degenerated to afib with ortho and antidromic conduction. PEARL #2: When AFib is fast — it often "looks" regular. Is There Atrial Activity in Figure-1?
OSA is commonly seen in patients with arrhythmias like atrialfibrillation (AFib) and due to the variable unpredictable nature of sleep apnea symptoms, it is often untreated, leading to adverse outcomes. Western Regional Director of Cardiac Electrophysiology, Northwell Health , NY.
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. 1 Approximately 33 million patients worldwide are living with AFib. adult population. Am J Cardiol 2013; 112:1142–1147.
During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrialfibrillation (AF). director of electrophysiology, Mount Sinai Fuster Heart Hospital , New York.
tim.hodson Thu, 03/27/2025 - 12:18 March 27, 2025 Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrialfibrillation (AFib). Today, approximately 8 million Europeans over the age of 65 are living with AFib, a number expected to double over the next 30 years.
milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people in the United States by 2050 and 17.9 million in Europe by 2060.
An international consensus statement on how to treat atrialfibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
Other vendors developing AI algorithms for electrophysiology (EP) settings include Anumana and Netherlands-based start-up YourRhythmics, which is developing algorithms which could provide clinical decision support to electrophysiologists in place of intrusive intracardiac ECG recordings.
The transaction follows Johnson & Johnson MedTech’s successful acquisitions of Abiomed , a leader in heart recovery, and more recently Laminar, an innovator in left atrial appendage elimination for patients with non-valvular atrialfibrillation (AFib).
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrialfibrillation (AF). link] ACC/AHA Release Updated AtrialFibrillation Guidelines for 2023. Sources: Joglar, J, Chung, M. J Am Coll Cardiol.
Patient course The patient was started on beta blockers and schedule for an electrophysiologic study. In any case, what would you do if you saw this? Try adenosine. It works for many forms of PAT and also of course for AVNRT or AVRT. Unfortunately, that EP study has not yet been done.
Boston Scientific made what could become a major addition to its electrophysiology portfolio, acquiring AFib mapping startup Cortex, Inc. Cortex might not be a household name outside of electrophysiology circles, debuting less than a year ago with $90M in funding, but it was actually formed from longtime EP mapping innovator Ablacon.
With this approval, Medtronic now offers two PFA technologies available for patients with Afib. With a short learning curve for experienced physicians, the possibilities are boundless for the treatment of Afib," said Vivek Reddy, M.D., tim.hodson Wed, 10/30/2024 - 13:42 Oct.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content